Evidence map

ReviewCurrent medicinal chemistry2025

TLR2 Activation as a Marker of Severe COVID-19 and a Potential Therapeutic Target.

Xianxian Mao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39484774